NanoVibronix, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NAOV research report →
Price Chart
About the company
NanoVibronix, Inc. , operating through its subsidiary NanoVibronix Ltd. , develops and commercializes innovative, non-invasive devices that stimulate biological responses for therapeutic purposes.
- CEO
- Doron Robert Besser
- IPO
- 2015
- Employees
- 31
- HQ
- Elmsford, NY, US
Get TickerSpark's AI analysis on NAOV
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.51M
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.41
- P/B
- 0.02
- EV/EBITDA
- -0.07
- Div Yield
- 0.00%
- Gross Margin
- -26.06%
- Op Margin
- -783.59%
- Net Margin
- -1088.94%
- ROE
- -60.47%
- ROIC
- -45.89%
Latest fiscal year · YoY change
- Revenue
- $2.55M-0.2%
- Gross Profit
- $153.00K-89.9%
- Op Income
- $-22,889,000
- Net Income
- $-18,185,000-390.8%
- EPS
- $-28.93-110.7%
- OCF Growth
- -272.5%
- FCF Growth
- -274.4%
- 52W High
- $162.50
- 52W Low
- $1.05
- 50D MA
- $4.70
- 200D MA
- $15.96
- Beta
- 2.06
- RSI (14)
- 43
- Avg Volume
- 86.23K
No earnings-call transcripts are available for NAOV yet.
- Free Float
- 100.0%
- Shares Outstanding
- 796.91K
- Float Shares
- 796.92K
of shares held by institutions
13 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Psagot Value Holdings Ltd. | 9.72K | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 30, 24 | Murphy Brian M | other | 80,000 |
| Dec 30, 24 | MIKA THOMAS | other | 20,000 |
| Dec 30, 24 | BROWN STEPHEN RUSSELL | other | 50,000 |
| Dec 30, 24 | Schroeder Maria | other | 20,000 |
| Dec 30, 24 | Goldstein Martin M | other | 23,000 |
| Dec 30, 24 | Ferguson Michael | other | 20,000 |
| Dec 30, 24 | JACOB HAROLD | other | 10,000 |
| Dec 30, 24 | FASHEK CHRISTOPHER M | other | 50,000 |
| Dec 30, 24 | Cassirer Aurora | other | 20,000 |
| Jan 23, 24 | MIKA THOMAS | other | 16,666 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our NAOV coverage
Recent articles, reports, and earnings notes.
No research on NAOV yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NAOV report →ENvue Medical Resumes U.S. Commercial Shipments of NanoVibronix PainShield® and Begins Fulfilling Open Distributor Orders
globenewswire.com · Sep 9
ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities
globenewswire.com · Aug 4
ENvue Medical Strengthens Patent Portfolio with New USPTO Notice of Allowance for Feeding Tube Combining Electromagnetic Navigation with Direct Visualization Through an Integrated Internal Camera
globenewswire.com · Feb 24
ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial
globenewswire.com · Jan 21
ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research
globenewswire.com · Jan 9
ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK
globenewswire.com · Dec 18
NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED'
businesswire.com · Dec 12
Head to Head Review: Veracyte (NASDAQ:VCYT) vs. Nanovibronix (NASDAQ:NAOV)
defenseworld.net · Dec 2
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.